Australian Clinical Labs Ltd (AU:ACL) has released an update.
Morgan Stanley has become a substantial holder in Australian Clinical Labs Limited, acquiring a 5.09% stake with 10,269,466 ordinary shares. The acquisition, which Morgan Stanley became aware of on September 18, 2024, includes shares held through various subsidiaries and involves both outright purchases and securities borrowed under agreements. The financial details of the transactions reveal a mix of cash payments and securities borrowing over recent months.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
